- Home
- DVN vs TEVA Comparison
DVN vs TEVA Comparison
Compare DVN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVN
- TEVA
- Stock Information
- Founded
- DVN 1971
- TEVA 1901
- Country
- DVN United States
- TEVA Israel
- Employees
- DVN N/A
- TEVA N/A
- Industry
- DVN Oil & Gas Production
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- DVN Energy
- TEVA Health Care
- Exchange
- DVN Nasdaq
- TEVA Nasdaq
- Market Cap
- DVN 22.2B
- TEVA 21.2B
- IPO Year
- DVN N/A
- TEVA N/A
- Fundamental
- Price
- DVN $31.76
- TEVA $20.03
- Analyst Decision
- DVN Buy
- TEVA Strong Buy
- Analyst Count
- DVN 21
- TEVA 7
- Target Price
- DVN $42.84
- TEVA $25.57
- AVG Volume (30 Days)
- DVN 7.1M
- TEVA 8.7M
- Earning Date
- DVN 11-05-2025
- TEVA 11-05-2025
- Dividend Yield
- DVN 3.00%
- TEVA N/A
- EPS Growth
- DVN N/A
- TEVA N/A
- EPS
- DVN 4.44
- TEVA N/A
- Revenue
- DVN $16,105,000,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- DVN $13.25
- TEVA $4.37
- Revenue Next Year
- DVN N/A
- TEVA $0.67
- P/E Ratio
- DVN $7.22
- TEVA N/A
- Revenue Growth
- DVN 7.79
- TEVA 2.08
- 52 Week Low
- DVN $25.89
- TEVA $12.47
- 52 Week High
- DVN $40.54
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- DVN 38.26
- TEVA 58.64
- Support Level
- DVN $31.47
- TEVA $18.83
- Resistance Level
- DVN $33.83
- TEVA $20.62
- Average True Range (ATR)
- DVN 0.73
- TEVA 0.46
- MACD
- DVN -0.05
- TEVA 0.01
- Stochastic Oscillator
- DVN 12.16
- TEVA 67.13
About DVN Devon Energy Corporation
Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. At the end of 2024, Devon reported net proved reserves of 2.2 billion barrels of oil equivalent. Net production averaged roughly 848,000 barrels of oil equivalent per day in 2024 at a ratio of 73% oil and natural gas liquids and 27% natural gas.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.